-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Jazz Pharmaceuticals plc quarterly/annual Depreciation history and growth rate from Q1 2011 to Q1 2024.
- Jazz Pharmaceuticals plc Depreciation for the quarter ending March 31, 2024 was $7.65M, a 1.04% increase year-over-year.
- Jazz Pharmaceuticals plc annual Depreciation for 2023 was $30.4M, a 0.36% increase from 2022.
- Jazz Pharmaceuticals plc annual Depreciation for 2022 was $30.3M, a 13.4% increase from 2021.
- Jazz Pharmaceuticals plc annual Depreciation for 2021 was $26.7M, a 43.1% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)